The investment case for TSMC is fairly straight forward: mobile computing and network/cloud infrastructure is driving the demand for complex semiconductor devices.
Buying Silevo is one reason. So is SolarCity's association with Tesla's Elon Musk.
Priceline would not be able to acquire a company like OpenTable had it not been one of the biggest winners in the stock market over the last decade.
There are still some opportunities out there for investors and some trends to exploit.
Biotech stocks are volatile but this related stock may be worth the interest.
You can't judge this market by the headlines. But India is showing much greater potential.
Given the limited opportunities available in the U.S. markets this year, it makes sense to look for attractive alternatives abroad such as India.
With the U.S. stock market in a lull, an overseas car company like Tata Motors beats Tesla.
Proofpoint offers some powerful solutions for computers and powerful returns to investors.
Over the past five years, Jazz Pharmaceuticals has grown an average of 175% a year.